123 related articles for article (PubMed ID: 31746087)
21. Randomized study of dose or schedule modification of granulocyte colony-stimulating factor in platinum-based chemotherapy for elderly patients with lung cancer.
Oshita F; Yamada K; Nomura I; Tanaka G; Ikehara M; Noda K
Oncol Rep; 2001; 8(4):861-6. PubMed ID: 11410799
[TBL] [Abstract][Full Text] [Related]
22. Calculated decisions: Absolute neutrophil count.
Patel S
Emerg Med Pract; 2018 Jan; 20(Suppl 1):1-2. PubMed ID: 29323858
[No Abstract] [Full Text] [Related]
23. Calculated decisions: MASCC Risk Index for febrile neutropenia.
Taylor J
Emerg Med Pract; 2018 Jan; 20(Suppl 1):3-4. PubMed ID: 29323859
[No Abstract] [Full Text] [Related]
24. Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice.
Kumar P; Bajpai J; Shetty N; Medekar A; Kurkure PA; Ghadyalpatil N; Gupta S; Noronha V; Kanujia A; Parikh P; Banavali SD
Indian J Cancer; 2014; 51(4):491-5. PubMed ID: 26842174
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil regeneration precedes healing of tissue destruction, as indicated by serum C-reactive protein, in children with cancer recovering from neutropenic fever.
Vettenranta K; Hovi L; Mäkipernaa A; Jalanko H; Saarinen-Pihkala UM
Acta Paediatr; 2002; 91(8):915-9. PubMed ID: 12222715
[TBL] [Abstract][Full Text] [Related]
26. Point-of-care method for total white cell count: an evaluation of the HemoCue WBC device.
Osei-Bimpong A; Jury C; McLean R; Lewis SM
Int J Lab Hematol; 2009 Dec; 31(6):657-64. PubMed ID: 18759736
[TBL] [Abstract][Full Text] [Related]
27. Four cases of spuriously low WBC count due to in vitro leukocyte agglutination: contribution of the hematology analyzer Coulter STKS in detecting this clinically misleading artefact.
Vinatier I; Capiod JC; Sassier P; Roussel B; Delobel J
Pathol Biol (Paris); 1994 Oct; 42(8):775-80. PubMed ID: 7724249
[TBL] [Abstract][Full Text] [Related]
28. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
Ammann RA; Bodmer N; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Popovic MB; Lüthy AR; Aebi C
J Clin Oncol; 2010 Apr; 28(12):2008-14. PubMed ID: 20231680
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic administration of granulocyte colony-stimulating factor when monocytopenia appears lessens neutropenia caused by chemotherapy for lung cancer.
Oshita F; Yamada K; Nomura I; Tanaka G; Ikehara M; Noda K
Am J Clin Oncol; 2000 Jun; 23(3):278-82. PubMed ID: 10857893
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and Haematological Predictors of Reduced Neutrophil Granulocyte Count associated with Intravenous Ceftriaxone Treatment.
Puri BK; Derham A; Monro JA
Rev Recent Clin Trials; 2018; 13(4):287-294. PubMed ID: 29769008
[TBL] [Abstract][Full Text] [Related]
31. Moxifloxacin-induced neutropenia in 26-year-old man.
Kula Atik T; Ispir E; Aytekin A; Turhan U; Yeniiz E; Tas D; Bedir O
J Infect Dev Ctries; 2018 Oct; 12(10):922-925. PubMed ID: 32004163
[TBL] [Abstract][Full Text] [Related]
32. [Leukopenia/neutropenia].
Bargetzi MJ
Ther Umsch; 2006 Jan; 63(1):78-82. PubMed ID: 16450737
[TBL] [Abstract][Full Text] [Related]
33. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia.
Bash RO; Katz JA; Cash JV; Buchanan GR
Cancer; 1994 Jul; 74(1):189-96. PubMed ID: 8004575
[TBL] [Abstract][Full Text] [Related]
34. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
35. Haematological point of care testing for clozapine monitoring.
Atkins M; McGuire P; Balgobin B; Desouza N; Taylor D
J Psychiatr Res; 2023 Jan; 157():66-71. PubMed ID: 36442408
[TBL] [Abstract][Full Text] [Related]
36. Neutropenia associated with beta-lactam antibiotics.
Kirkwood CF; Smith LL; Rustagi PK; Schentag JJ
Clin Pharm; 1983; 2(6):569-78. PubMed ID: 6653059
[TBL] [Abstract][Full Text] [Related]
37. Restorative effect of muroctasin on leukopenia caused by anticancer chemotherapy in lung cancer. Comparative study by envelope method.
Fukuoka M; Takada M; Takifuji N; Sakai N; Ryu S; Masuda N; Matsui K; Negoro S; Kusunoki Y; Tubura E
Arzneimittelforschung; 1989 Jan; 39(1):90-3. PubMed ID: 2719748
[TBL] [Abstract][Full Text] [Related]
38. Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.
Coyne CJ; Le V; Brennan JJ; Castillo EM; Shatsky RA; Ferran K; Brodine S; Vilke GM
Ann Emerg Med; 2017 Jun; 69(6):755-764. PubMed ID: 28041827
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the performance of a point-of-care method for total and differential white blood cell count in clozapine users.
Bui HN; Bogers JP; Cohen D; Njo T; Herruer MH
Int J Lab Hematol; 2016 Dec; 38(6):703-709. PubMed ID: 27565762
[TBL] [Abstract][Full Text] [Related]
40. [Effect of G-CSF (nartograstim) on neutropenia (leukopenia) induced by taxane in metastatic breast cancer--time-course changes in neutrophil and leukocyte counts].
Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Nagumo H; Utada Y; Okabe T; Kimura K; Hirano A; Kajiwara T
Gan To Kagaku Ryoho; 2001 Jun; 28(6):815-9. PubMed ID: 11432350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
